Article Details

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024

Retrieved on: 2024-04-30 23:53:39

Tags for this article:

Click the tags to see associated articles and topics

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024. View article details on hiswai:

Excerpt

SAN FRANCISCO --(BUSINESS WIRE)--Apr. 30, 2024-- Vir Biotechnology , Inc. (Nasdaq: VIR) today announced that Marianne De Backer , M.Sc ., Ph.D., ...

Article found on: markets.ft.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up